Founded
7 Aug 2006
Address
Alta Partners LP
One Embarcadero Center
37th Floor
San Francisco, CA 94111
United States
Phone
Website
Industry
Business classification
VCID: 30601
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Alta Partners VIII | Venture | 2006 |
| Alta California Partners IV | Venture | 2004 |
| Alta BioPharma Partners III LP | Venture | 2003 |
| Alta BioPharma Partners II LP | Venture | 2000 |
| Alta California Partners III LP | Venture | 2000 |
| Alta California Partners II LP | Venture | 1999 |
| Alta BioPharma Partners LP | Venture | 1998 |
| Alta California Partners LP | Venture | 1996 |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Trevena Inc |
United States | 10 May 2013 | Series C Active |
|
|
Lumena Pharmaceuticals Inc |
United States | 8 May 2013 | Series A Active |
|
|
|
SARcode Bioscience Inc |
United States | 1 Jul 2011 | Series B |
|
|
|
Aerie Pharmaceuticals Inc |
United States | 1 Mar 2011 | Series B Active |
|
|
|
Chimerix Inc |
United States | 1 Aug 2009 1 Feb 2011 |
Series F |
|
|
|
aTyr Pharma Inc |
United States | 1 Apr 2007 1 Oct 2010 |
Series C Active |
|
|
|
Nereus Pharmaceuticals Inc |
United States | 1 Aug 2007 1 Jun 2010 |
Series E |
|
|
TransMedics Inc |
United States | 13 Apr 2007 30 Mar 2010 |
Series E Round participant. Active |
|
|
|
Coapt Systems Inc Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. |
United States | 1 Dec 2009 | Debt Active |
|
|
|
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Nov 2009 | N/A |
|
|
|
Avid Radiopharmaceuticals Inc |
United States | 1 May 2009 | Series D Active |
|
|
|
Aerovance Inc |
United States | 1 Apr 2009 | N/A Active |
|
|
|
Intradigm Corp |
United States | 1 Jan 2009 | Series B |
|
|
|
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. |
United States | 1 Nov 2008 | Series A |
|
|
|
Agami Systems Inc |
United States | 21 Nov 2007 | Series C Initial investment. Round participant. Active |
|
|
|
Paracor Medical Inc Developed a ventricular elastic support therapy |
United States | 1 Jun 2007 | Series D |